Lyon Street Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Lyon Street Capital’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,807	Closed	-$624K	–	88
2020 Q2	$624K	Buy	+13,807	New	+$619K	1.25%	36
2020 Q1	–	Sell	-31,013	Closed	-$1.44M	–	90
2019 Q4	$1.44M	Buy	31,013 +6,168	+25%	+$267K	2.44%	10
2019 Q3	$1.01M	Sell	24,845 -28,178	-53%	-$1.22M	1.86%	26
2019 Q2	$2.55M	Buy	53,023 +38,182	+257%	+$2.01M	4.34%	2
2019 Q1	$929K	Sell	14,841 -15,928	-52%	-$1.09M	2.86%	10
2018 Q4	$1.84M	Sell	30,769 -524	-2%	-$31.5K	1.85%	20
2018 Q3	$2.02M	Sell	31,293 -181,341	-85%	-$10.1M	1.26%	24
2018 Q2	$9.57M	Sell	212,634 -128,443	-38%	-$5.12M	3.4%	6
2018 Q1	$10.6M	Sell	341,077 -37,952	-10%	-$1.25M	3.41%	9
2017 Q4	$11.3M	Buy	379,029 +363,677	+2,369%	+$10.5M	3.78%	6
2017 Q3	$507K	Buy	+15,352	New	+$532K	0.2%	55

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Lyon Street Capital's BEAT Position: Q3 2020 in Review

Lyon Street Capital sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 13,807 shares — an estimated $624K sold.

Lyon Street Capital first reported a position in BEAT in Q3 2017 and held it in 11 quarters. The position peaked at $11.3M in Q4 2017. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

Lyon Street Capital reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
Lyon Street Capital sold 13,807 BioTelemetry, Inc. shares in Q3 2020, an estimated $624K.
Lyon Street Capital first reported a position in BioTelemetry, Inc. in Q3 2017 and held it in 11 quarters.
Lyon Street Capital's BioTelemetry, Inc. position peaked at $11.3M in Q4 2017.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Lyon Street Capital's 13F filing for Q3 2020, filed 16 Nov 2020.